The table below shows aTYR PHARMA INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$12.52M
-$15.42M
-$22.38M
-$590.00K
-$10.12M
-$5.83M
Capital expenditure
$138.00K
$0.00
$17.00K
$1.25M
$43.00K
$17.00K
Investing cash flow
$11.49M
-$4.42M
-$1.36M
-$38.17M
$14.63M
-$23.39M
Dividends paid
-
-
-
LIFE operating cash flow (10-K history)
aTYR PHARMA INC reported operating cash flow of -$61.99M for fiscal year 2025. That is up 10.3% from -$69.12M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$52.86M (FY 2016) to -$61.99M. Figures come from the company's audited annual reports as filed with the SEC.
